Clinical Trials Directory

Trials / Unknown

UnknownNCT03391687

Incidence of Pancreatic Fistula After Radical Gastrectomy

Investigation of Incidence of Pancreatic Fistula After Radical Gastrectomy in Gastric Cancer Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
2,100 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is designed to investigate the incidence of pancreatic fistula after radical gastrectomy in gastric cancer patients.

Detailed description

Pancreatic fistula, which can lead to fatal end, is one of the most serious complications after radical gastrectomy. It is usually treated as a key factor to evaluate the quality of gastrectomy. The incidence of pancreatic fistula is far different between different areas, knowing the prevalence of pancreatic fistula and risk factors can help us to prevent pancreatic fistula and improve the short time outcome of gastric cancer surgery treatment. So, we designed this perspective, multi-center study to investigate the incidence of pancreatic fistula and its outcome in China.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAmylase Testbody fluid amylase will be tested after radical gastrectomy in scheduled interval

Timeline

Start date
2017-12-01
Primary completion
2018-11-30
Completion
2018-11-30
First posted
2018-01-05
Last updated
2018-01-05

Locations

21 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03391687. Inclusion in this directory is not an endorsement.